Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Interventional Cardiology
Do you prefer using unfractionated heparin or low molecular weight heparin in stable patients presenting with NSTE ACS awaiting primary PCI (assuming normal renal function)?
Related Questions
How do you view the balance between opting for percutaneous coronary intervention and prioritizing optimal medical therapy as the initial treatment choice for patients with stable angina?
How soon after an elective, uncomplicated coronary intervention would you feel comfortable having a patient travel by air?
Do you recommend routine use of protamine for hemostasis at the end of a transfemoral TAVI?
What is/are your preferred technique(s) for obtaining LV-Ao pressure gradients in the cath lab?
When pursuing complex PCI of the RCA (especially when lesion preparation is required), when do you consider placing a transvenous pacemaker in anticipation of conduction abnormalities?
What is your preferred duration for triple therapy post-PCI in patients on systemic anticoagulation?
What techniques do you use in the lab to reduce the amount of contrast that needs to be used in patients with CKD?
What is your intraprocedural approach to reducing time to reperfusion in STEMI cases: opting for culprit lesion PCI first then complete angiography, or complete angiography followed by culprit lesion PCI?
What has been your approach to percutaneous intervention for calcified nodules and threshold for intervention?
What factors influence your choice between low-dose DOAC therapy and dual antiplatelet therapy for the first 3 months after percutaneous left atrial appendage occlusion?
